Institute of Innate Immunity, University Hospitals Bonn, 53127 Bonn, Germany.
Institute of Innate Immunity, University Hospitals Bonn, 53127 Bonn, Germany; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA; German Center of Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany; Centre for Molecular Inflammation Research (CEMIR), Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Cell Metab. 2017 Jul 5;26(1):71-93. doi: 10.1016/j.cmet.2017.06.018.
Inflammasomes are protein complexes formed upon encounter of microbial or damage-associated stimuli. The main output of inflammasome assembly is activation of caspase-1, a protease involved in both pro-inflammatory and host-protective responses. Defined bacterial or viral ligands have been identified for the inflammasome-forming receptors AIM2, NLRP1, and NLRC4. The signals activating other inflammasomes, NLRP3, NLRP6, and pyrin, are less well understood. Recent studies implicated several low-molecular-weight compounds traditionally linked to metabolism, not immunity, in modulation of inflammasome signaling. Furthermore, genetic, pharmacological, or pathogen-mediated interference with energy metabolism also affects inflammasome activation. Here we review the findings on how microbial- and host-derived metabolites regulate activation of the NLRP3 and NLRP6 inflammasomes. We discuss the different models of how glycolysis and mitochondrial metabolism control the NLRP3 inflammasome. Finally, we summarize the findings on metabolic control of pyrin and point to open questions to be addressed to broaden our understanding of metabolism-inflammasome interactions.
炎症小体是在遇到微生物或损伤相关刺激时形成的蛋白质复合物。炎症小体组装的主要产物是半胱天冬酶-1 的激活,半胱天冬酶-1 是一种参与促炎和宿主保护反应的蛋白酶。已经确定了用于形成炎症小体的受体 AIM2、NLRP1 和 NLRC4 的定义性细菌或病毒配体。激活其他炎症小体 NLRP3、NLRP6 和 pyrin 的信号了解得较少。最近的研究表明,几种传统上与代谢而非免疫相关的低分子量化合物在炎症小体信号转导的调节中起作用。此外,遗传、药理学或病原体介导的能量代谢干扰也会影响炎症小体的激活。在这里,我们回顾了微生物和宿主衍生代谢物如何调节 NLRP3 和 NLRP6 炎症小体激活的发现。我们讨论了糖酵解和线粒体代谢控制 NLRP3 炎症小体的不同模型。最后,我们总结了代谢对 pyrin 的控制,并指出了有待解决的问题,以扩大我们对代谢-炎症小体相互作用的理解。